JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265886

Human MVB12A (FAM125A) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

MVB12A KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 1 and 40 bp deletion in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
2 Images
Sanger Sequencing - Human MVB12A (FAM125A) knockout HeLa cell line (AB265886)
  • Sanger seq

Unknown

Sanger Sequencing - Human MVB12A (FAM125A) knockout HeLa cell line (AB265886)

Allele-1 : 1 bp insertion in exon 1.

Sanger Sequencing - Human MVB12A (FAM125A) knockout HeLa cell line (AB265886)
  • Sanger seq

Unknown

Sanger Sequencing - Human MVB12A (FAM125A) knockout HeLa cell line (AB265886)

Allele-2 : 40 bp deletion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 1 and 40 bp deletion in exon 1

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265886-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265886-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265886 Human MVB12A (FAM125A) knockout HeLa cell line", "number":"AB265886-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265886-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265886 Human MVB12A (FAM125A) knockout HeLa cell line", "number":"AB265886-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265886-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265886-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265886 Human MVB12A (FAM125A) knockout HeLa cell line", "number":"AB265886-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265886-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265886 Human MVB12A (FAM125A) knockout HeLa cell line", "number":"AB265886-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
MVB12A
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

FAM125A also known as MVB12A is a protein involved in the endosomal sorting complex required for transport particularly the ESCRT-I complex. It is about 26 kDa in mass and plays a role in cargo recognition during the sorting process. FAM125A is expressed in many tissues including the central nervous system indicating its wide functional relevance.
Biological function summary

FAM125A participates in the ESCRT machinery which is essential for the regulation of endosomal trafficking. It associates with other proteins such as TSG101 within the ESCRT-I complex facilitating the sorting of ubiquitinated membrane proteins into multivesicular bodies. This activity is vital for processes like receptor down-regulation and virus budding indicating its significant involvement in cellular homeostasis.

Pathways

FAM125A significantly engages in the endocytic and lysosomal degradation pathways. It works closely with ESCRT-I complex partners such as VPS37 and TSG101 aiding in membrane remodeling and protein trafficking. The ESCRT pathway is important for maintaining proper cell signaling and membrane composition linking FAM125A functionally to cellular maintenance and response processes.

FAM125A has associations with neurogenerative conditions and certain cancers. Disrupted endosomal sorting might contribute to pathological states where protein aggregation or receptor recycling is impaired such as in Alzheimer's disease. Additionally FAM125A and ESCRT-related proteins like VPS37 may play roles in tumor progression and metastasis as proper endosome function is necessary to control cell division and migration signals.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com